https://www.nejm.org/doi/full/10.1056/NEJMoa2312323?query=TOC&cid=NEJM%20eToc,%20April%204,%202024%20DM2334659_NEJM_Non_Subscriber&bid=-2093479170
IMO, this is an important study but has quite a lot of side effects, however.
Lixisenatide helps a bit the progression of PD
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $10.54K | 2.185M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 59 | 83226460 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 20397608 | 18 |
View Market Depth
| Last trade - 10.13am 07/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |